Merck Jobs & Careers Search

Find your next job at Merck. Search Merck jobs from thousands of job and career search sites. A search engine for jobs with a different approach to job and career searches. In one simple search, job seekers get free access to millions of employment opportunities from thousands of websites. Find your next job at Merck today.

Gardasil Side Effects Tough to Monitor
Deborah Kotz

Gardasil, the vaccine that protects against the cervical-cancer-causing human papillomavirus, got a bit of a smack-down from two studies published in the Journal of the American Medical Associationdetailing safety risks associated with ...

MERCK SHARP & DOHME CORP. Financials (EDGAR Online Financials)

Living Without Blockbusters (at Forbes.com)

Alcon Boosts Presence In Eye Disease Market (Investor's Business Daily)
Ophthalmic drug and device maker Alcon eyes big returns from a pair of deals it signed over the past two months.

10 Dividend Stocks for Enterprising Investors (at Seeking Alpha)

3 Investments That Will Cut Your Taxes (at Motley Fool)

Specialty Pharma Stock Picks From David Amsellem Of Piper Jaffray (Wall Street Transcript)
67 WALL STREET, New York - November 6, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Ariad's 3Q loss widens slightly on costs (AP)
Drug developer Ariad Pharmaceuticals Inc. said Thursday its third-quarter loss widened slightly on overall costs as it continues developing potential cancer treatments.

The Top 4 Healthcare Dividend Stocks: Covered Call Trades (at Seeking Alpha)

2 Takeover Targets in the Pharma Market (at CNBC)

Slow Down There, Merck (at Motley Fool)

AmerisourceBergen Profitably Pushing Drugs (at Investopedia)

Placing Bets On Human Genome's Benlysta (Indie Research)
There has been a lot of hype surrounding Human Genome Sciences' lupus drug recently.

Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships (Wall Street Transcript)
67 WALL STREET, New York - November 5, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

[video] Don't Buy the Jobs Hype (at TheStreet.com)

Biotech Stocks: Drug stocks gain; Alnylam slides (at MarketWatch)

Wednesday's Biggest Stock Stars (at Motley Fool)

A 130 / 30 Global Pharma Strategy (at Seeking Alpha)

[$$] Garmin Gets Lost As Merck Rises 6.4% (at The Wall Street Journal Online)

Stocks give up some gains after Fed (at CNNMoney.com)
Wall Street abandons the rally late in the session as investors consider weak banking sector, the central bank's decision to hold rates steady.

Merck CEO 'Actively Looking' for Biotech Deals (at The Wall Street Journal Online)

Merging Merck
Why bigger makes our company better.

A Shot In The Arm For The Pap Smear
Is Merck's Gardasil the best solution for cervical cancer?

The Cybercure
From computer modeling to hospital robots, can information technology fix health care?

The Disease Machine
Can software synthesize what we know about human biology into one clear picture? Stephen Friend thinks so.

McCormick Gets A Little Spice Out Of Lawry's
The spice merchant posts a nice boost in earnings thanks to its gobbling up of an erstwhile competitor.

Merck's Top Brass Stays Put
There are a lot of musical chairs involved in the company's merger with Schering, but big names aren't playing.

Why Pharma Wants ObamaCare
There are reasons it could be good for drug companies--and they're not what you think.

Merck's AIDS Triumph
It went where other drug companies feared to tread and got a big-selling HIV drug.

Street Shaky As Bernanke Testifies
Fed outlines exit strategy; Coca-Cola earnings take a hit.

Bernanke Outlines Exit Strategy
Investors sort through earnings from Caterpillar, Coca-Cola.

Week Ahead: Microsoft, Yahoo!, AT&T
Investors brace for existing home sales; Merck, Starbucks, Boeing report.

Another Downer For Merck's Cholesterol Drugs
Why investors are right to worry that a new study could damage the company's outlook.

Merck's Heart Failure Failure
One of the drug industry's most renowned names is having a lot of trouble landing new drugs.

Could Merck Become Pharma's Yield King?
Analyst expects the company will boost dividend after its merger with Schering-Plough.

The Flu Vaccine Accelerator
To stop a pandemic, we need something faster than a chicken egg. VaxInnate holds out hope.

How To Maintain FDA Standards
Don't follow Marcia Angell's recommendations.

Merck, Schering Results Highlight Merger Need
Quarterly numbers show why Merck decided, after years of merger aversion, to buy Schering-Plough.

The Profit Pill
How one drug allowed Gilead Sciences to beat big pharma at its own game.

Politics Versus Economics In A Recession
Politicians like to exert their influence on the economy, but it can be tough when markets move this fast.

Obama Taps New FDA Leaders
White House seeks to bolster food and drug safety.

Relief For Roche After Genentech Deal
Shares of the Swiss drug maker rise after sealing a long-awaited takeover.

The End Of Merck
Merck's executives may have saved their company by losing what made it special.

Stocks Slip Ahead Of Treasury Auction
Street takes a beating but prepares for consumer confidence reports and a speech from Bernanke.

The Next Pharma Buyouts
Pfizer bought Wyeth; Merck nabbed Schering. Here's the next wave of possible suite mates.

Stocks Close Down On News Of Merck-Schering Deal
This is a transcript of the Market Update: Close video report.

Living Without Blockbusters
Sanofi-Aventis' Christopher Viehbacher is slashing R&D and moving into emerging countries. 2009 11 06 18:40

Final Glance: Pharmaceuticals companies
NEW YORK (AP) - Shares of some top pharmaceuticals companies were mixed at the close of trading: 2009 11 06 17:55

3 Investments That Will Cut Your Taxes
Don't make the IRS your friend. 2009 11 06 08:09

Ariad's 3Q loss widens slightly on costs
CAMBRIDGE, Mass. (AP) - Drug developer Ariad Pharmaceuticals Inc. said Thursday its third-quarter loss widened slightly on overall costs as it continues developing potential cancer treatments. 2009 11 06 08:07

Slow Down There, Merck
More acquisitions already? 2009 11 05 11:40

Don't Buy the Jobs Hype
NEW YORK (TheStreet) - - David Henderson of Dru Strocks sees past today's jobs data hype and is bracing for a negative payroll number on Friday. 2009 11 05 10:55

Deals of the Day: What if Oracle Walks Out on Sun?
2009 11 05 09:41

New Merck Begins Operations

Merck and Schering-Plough to Complete Merger Today

Merck and Schering-Plough Receive Approvals From U.S. Federal Trade Commission, Swiss Competition Commission and Canadian Competition Bureau for Merger

Merck Announces Third-Quarter 2009 Financial Results

Merck to Hold Third-Quarter 2009 Sales and Earnings Conference Call on Oct. 22

Merck Announces Fourth-Quarter 2009 Dividend

Access Feature Story: Helping to Protect the Sight of Future Generations

Access Feature Story: Providing Free Vaccinations to Nicaraguan Babies

Environment Feature Story: A Shining Example of Environmental Commitment

Community Feature Story: Helping to Close the Gaps in Diabetes Care

Community Feature Story: Providing Meals to Those in Need

Community Feature Story: Working in the Community to Help Fight Childhood Asthma

Access Feature Story: Fighting HIV/AIDS in Botswana

Access Feature Story: Merck Helps: The Merck U.S. Patient Assistance Program

CDC Advisory Committee on Immunization Practices Votes for Permissive Use and for Vaccines for Children Funding for GARDASIL® for Boys and Young Men

FDA Approves GARDASIL® for Use in Boys and Young Men

Merck Receives Positive CHMP Opinion for JANUVIA® (sitagliptin) and JANUMET® (sitagliptin/metformin) as Add-On to Insulin in the European Union

Merck & Co., Inc. (NYSE: MRK)

Merck & Co., Inc. (NYSE: MRK) is one of the largest pharmaceutical companies in the world. The headquarters of the company is located in Whitehouse Station, NJ. It was established in 1891 as the United States subsidiary of the German company now known as Merck KGaA. In common with many other German assets in the United States, Merck & Co. was confiscated in 1917 during World War I and set up as an independent company. It is currently one of the top 7 largest pharmaceutical companies in the world both by capital and revenue.

Merck & Co. describes itself as a "a global research-driven pharmaceutical company." Merck discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures.